Kayne DL 2021, Inc.
Other · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Operating income | — | — | — | — | — |
| Net income | $29.8M | $27.0M | $16.7M | $4.8M | −$121,000 |
| Total assets | $359.7M | $280.4M | $189.8M | $109.1M | $43.5M |
| Total liabilities | $9.6M | $8.0M | $5.3M | $3.2M | $648,000 |
| Equity | $350.1M | $272.5M | $184.6M | $105.9M | $42.9M |
| EPS (diluted) | — | $609.00 | $600.00 | $435.00 | $-18.00 |
| Shares out. | 56,769 | 40,886 | 25,668 | 20,554 | 8,600 |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- —
- Net margin
- —
- Return on equity
- 8.5%
- Return on assets
- 8.3%
- Return on capital (ROCE)
- —
- Liabilities / assets
- 2.7%
- Debt / equity
- 0.03×
- Book value / share
- $6167.15
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- 10.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Accruals / assets
- 22.0%high accruals
- Piotroski F-Score
- 2/6weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 2 warning● 1 good- Negative operating cash flow
- High accruals — earnings-quality risk
- Conservative leverage (liabilities < 50% of assets)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Uaw Retiree Medical Benefits TrustActivist (13D)Aug 15, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Material events
SEC Form 8-K · most recent- Unregistered equity saleAug 14, 2025
- Shareholder voteJun 17, 2025
- Unregistered equity saleMay 2, 2025
- Other material eventFeb 24, 2025
- Unregistered equity saleFeb 18, 2025
- Unregistered equity saleOct 25, 2024
- Shareholder voteJun 21, 2024
- Other material eventMay 10, 2024
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 10-QMay 11, 2026
- DEF 14APROXY STATEMENTApr 24, 2026
- 10-KANNUAL REPORTMar 2, 2026
- 40-APP/ADec 17, 2025
- 40-17GDec 2, 2025
- 10-QQUARTERLY REPORTNov 10, 2025
- 40-APP/AOct 1, 2025
- 4OWNERSHIP DOCUMENTAug 15, 2025
- SCHEDULE 13D/AAug 15, 2025
- 8-KCURRENT REPORTAug 14, 2025
- 4PRIMARY DOCUMENTAug 13, 2025
- 10-QQUARTERLY REPORTAug 11, 2025
- 40-APPJun 30, 2025
- 8-KCURRENT REPORTJun 17, 2025
- 10-QQUARTERLY REPORTMay 12, 2025
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.